Search
for
Sort by
Research 151–180 of 1000+
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Recent approaches of antibody therapeutics in androgenetic alopecia
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- To evaluate the causes and possible treatments for alopecia seborrheic in adolescents
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- Vitiligo - Part 2 - classification, histopathology and treatment
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Modern hair restoration surgery
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management
- Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Changes in immune status parameters in patients with alopecia areata undergoing combined therapy
- Triton modified polyethyleneimine conjugates assembled with growth arrest-specific protein 6 for androgenetic alopecia transdermal gene therapy
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- From Primary MSC Culture of Adipose Tissue to Immortalized Cell Line Producing Cytokines for Potential Use in Regenerative Medicine Therapy or Immunotherapy
- 0009 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo and represent potential therapeutic target
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Increase in IL-15 levels in patients with alopecia areata
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism